Historic legislation was introduced earlier today in the United States Senate. Sens. Rand Paul (R-KY), Cory Booker (D-NJ), and Kirsten Gillibrand (D-NY) announced the introduction of the Compassionate Access, Research Expansion, and States’ Rights (CARERS) Act. This is the first time legislation that would make medical marijuana legal under federal law has been introduced in the Senate.
First and foremost, the bill would make production, distribution, and possession of marijuana for medical purposes that’s legal under state law legal under federal law. The bill would also remove barriers to scientific research, allow Veterans Administration physicians to recommend medical marijuana, allow interstate transportation of CBD oils, ensure medical marijuana dispensaries are taxed fairly, and allow all marijuana businesses — including adult-use stores in Colorado and elsewhere — to access the banking system and no longer be forced to operate on a cash-only basis.
There’s no reason your senators shouldn’t be co-sponsoring this bill. Please email their offices and ask them to sign on.
The Smarter Sentencing Act (S. 1410), sponsored by a bipartisan coalition including Dick Durbin (D-IL) and Mike Lee (R-UT), would bring real change to destructive mandatory minimum sentences in our criminal justice system. Aside from saving billions of dollars spent on incarcerating nonviolent drug offenders, the bill would give judges more flexibility in sentencing those with minor criminal records.
More specifically, some current mandatory minimum sentences would be cut in half. That means that if this bill passes, we could potentially see 10 and five-year mandatory minimum sentences for marijuana offenses cut to five and 2.5 years, respectively. This would be a huge victory, and we need your help to secure the votes.
Senate Majority Leader Harry Reid recently announced that he wants to bring the Smarter Sentencing Act up for a vote in the Senate this summer. Twenty-four senators have co-sponsored the bill already, but we need to secure 60 votes to pass the bill on the floor. The House companion bill, H.R. 3382, already has a bipartisan coalition consisting of 33 co-sponsors.
The good news is we will get a vote thanks to two courageous senators who are taking a stand for medical marijuana patients and respecting state laws. Sen. Rand Paul (R-KY) and Sen. Cory Booker (D-NJ) are sponsoring an amendment identical to the one that passed in the House last month. The amendment was filed yesterday and could be voted on at any time.
You read that correctly — Congress just voted to end the federal government’s war on medical marijuana!
During a debate regarding a Justice Department funding bill, Rep. Dana Rohrabacher (R-CA), a longtime MPP ally, offered an amendment intended to block DEA raids on medical marijuana dispensaries. It passed by a surprisingly wide margin — 219-189. The amendment will not become law until it is signed by the president, but we’re well on our way.
MPP played a key role in building support for this measure, and we couldn’t have done it without our supporters.
We have had a lot of victories since MPP was founded in 1995, but this is one of the biggest — not just in the organization’s history, but in the history of the marijuana policy reform movement.
We worked with Congressman Rohrabacher and former Congressman Maurice Hinchey on this amendment for more than a decade, and our lobbying presence in Congress has never been stronger. This year alone, we met with staffers from more than 100 congressional offices, as well as dozens of members in person. With this victory, even more doors will be open to us in the future.
U.S. Rep. Steve Cohen (D-TN) introduced a bill Tuesday that would change federal law so that the director of the Office of National Drug Control Policy (ONDCP), commonly known as the “drug czar,” is no longer prohibited from studying the legalization of marijuana and no longer required to oppose attempts to legalize marijuana for medical or broader adult use.
Specifically, H.R. 4046, the Unmuzzle the Drug Czar Act of 2014, would amend the Office of National Drug Control Policy Reauthorization Act of 1998 to remove the following language from the obligations of the director:
(12) shall ensure that no Federal funds appropriated to the Office of National Drug Control Policy shall be expended for any study or contract relating to the legalization (for a medical use or any other use) of a substance listed in schedule I of [the Controlled Substances Act] and.take such actions as necessary to oppose any attempt to legalize the use of a substance (in any form) that –
(A) is listed in schedule I of section 812 of this title; and
(B) has not been approved for use for medical purposes by the Food and Drug Administration;
Rep. Cohen and other members of the House Committee on Oversight and Government Reform slammed the ONDCP during a hearing last week. Rep. Cohen chided the office for failing to address the National Institute on Drug Abuse’s obstruction of research into the medical benefits of marijuana. Rep. Earl Blumenauer (D-OR) criticized it for relying on marijuana “propaganda.” ONDCP Deputy Director Michael Botticelli drew criticism for refusing to acknowledge that marijuana poses less potential harm to the consumer than heroin or methamphetamine.